Abcam plc: Consultation on 2020 LTIP Awards
November 03 2020 - 7:30AM
Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply
of life science research tools, announces that, following
consultation with shareholders on the Group’s overall LTIP
structure and performance framework, including proposed changes for
this year’s awards, it has determined to retain the existing LTIP
metrics and targets contained in Abcam’s current Remuneration
Policy, as approved by shareholders in 2018.
Furthermore, Abcam intends to continue
consulting with shareholders in the coming months in relation to
its proposals for a new Remuneration Policy which will then be put
forward to shareholders for approval.
For further information, please contact:
Abcam |
+ 44 (0) 1223 696 000 |
Marc
Perkins, Company Secretary James Staveley, Vice President, Investor
Relations |
|
|
|
Numis – Nominated Advisor & Joint Corporate
Broker |
+ 44 (0) 20
7260 1000 |
Garry Levin
/ Duncan Monteith / Huw Jeremy |
|
About Abcam plc
As an innovator in reagents and tools, Abcam’s
purpose is to serve life science researchers globally to achieve
their mission, faster. Providing the research and clinical
communities with tools and scientific support, the Company offers
highly validated biological binders and assays to address important
targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce
in the life sciences, Abcam’s ambition is to be the most
influential company in life sciences by helping advance global
understanding of biology and causes of disease, which, in turn,
will drive new treatments and improved health.
In the fiscal year ended 30 June 2020, Abcam’s
worldwide customer base consisted of approximately 750,000 life
science researchers. By actively listening to and collaborating
with these researchers, the Company continuously advances its
portfolio to address their needs. A transparent programme of
customer reviews and datasheets, combined with an industry-leading
validation initiative, gives researchers increased confidence in
their results.
Founded in 1998 and headquartered in Cambridge,
UK, the Company has served customers in to more than 130 countries.
Abcam’s ordinary shares were admitted to trading on AIM in 2005
(AIM: ABC) and its American Depositary Shares began trading on the
Nasdaq Global Market in October 2020 (Nasdaq: ABCM).
Please visit www.abcam.com or www.abcamplc.com
to find out more.
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Apr 2024 to May 2024
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From May 2023 to May 2024